Glynne-Jones, Robert, Sebag-Montefiore, David, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Gollins, Simon, Harrison, Mark, Meadows, Helen M. and Jitlal, Mark 2013. Prognostic factors for recurrence and survival in anal cancer. Cancer 119 (4) , pp. 748-755. 10.1002/cncr.27825 |
Harrop, Emily ORCID: https://orcid.org/0000-0003-2820-0023, Kelly, John, Neal, David, Dasgupta, Prokar, Basnett, Gillian, Huddart, Robert, Barham, Allan, Thompson, Colin, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Jundi, Hala, Griffiths, Gareth and Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425 2013. ‘Once I knew there was a choice, I wanted to exercise that choice': using qualitative methods to understand why patients decline surgical trials. Trials 14 (S1) , P9 (2013). 10.1186/1745-6215-14-s1-p9 |
Khan, A. R., Riaz, M. ORCID: https://orcid.org/0000-0002-5512-1745, Bin Abdulhak, A. A., Al-Tannir, M. A., Garbati, M. A., Erwin, P. J., Baddour, L. M. and Tleyjeh, I. M. 2013. The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. PLoS ONE 8 (1) , e52929.. 10.1371/journal.pone.0052929 |
Powell, James R., Dojcinov, Stefan, King, Louise, Wosniak, Sue, Gerry, Stephen, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Bailey, Hazel, Gallop-Evans, Eve and Maughan, Tim 2013. Prognostic significance of hypoxia inducible factor-1α and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximab. Leukemia & Lymphoma 54 (5) , pp. 959-966. 10.3109/10428194.2012.733875 |
Smith, Chris, Fisher, D., Claes, B., Maughan, T. S., Idziaszczyk, Shelley, Peuteman, G., Harris, Rebecca, James, Michelle D., Meade, A., Jasani, Bharat, Adams, Richard A. ORCID: https://orcid.org/0000-0003-3915-7243, Kenny, S., Kaplan, R., Lambrechts, D. and Cheadle, Jeremy P. ORCID: https://orcid.org/0000-0001-9453-8458 2013. Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab. Clinical Cancer Research 19 (15) , pp. 4104-4113. 10.1158/1078-0432.CCR-12-2581 |
Smith, Chris, Naven, Marc ORCID: https://orcid.org/0000-0002-6339-3257, Harris, Rebecca, Colley, James, West, Hannah, Li, Ning, Liu, Yuan, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Maughan, Timothy S., Nichols, Laura, Kaplan, Richard, Wagner, Michael J., McLeod, Howard L. and Cheadle, Jeremy P. ORCID: https://orcid.org/0000-0001-9453-8458 2013. Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer. Human Mutation 34 (7) , pp. 1026-1034. 10.1002/humu.22333 |
Türbachova, Ivana, Schwachula, Tim, Vasconcelos, Ines, Mustea, Alexander, Baldinger, Tina, Jones, Katherine A, Bujard, Hermann, Olek, Alexander, Olek, Klaus, Gellhaus, Katharina, Braicu, Ioana, Könsgen, Dominique, Fryer, Christy, Ravot, Elisabetta, Hellwag, Alexander, Westerfeld, Nicole, Gruss, Oliver J, Meissner, Markus, Hassan, Mazahir, Weber, Michael, Hoffmüller, Ulrich, Zimmermann, Sven, Loddenkemper, Christoph, Mahner, Sven, Babel, Nina, Berns, Els, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Zeilinger, Robert, Baron, Udo, Vergote, Ignace, Maughan, Tim, Marme, Frederik, Dickhaus, Thorsten, Sehouli, Jalid and Olek, Sven 2013. The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns. Epigenetics 8 (11) , pp. 1226-1235. 10.4161/epi.26334 |